| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | PGP9.5, 1-223aa, Human, E.coli (Bioactivity Validated) |
|---|
| Description | Purity: > 95% by SDS - PAGE Format: Liquid. In 20mM Tris-HCl pH8.0, 2mM EDTA . PGP9.5/uCH-L1 is a member of a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to generate the ubiquitin monomer. PGP9.5 is a component of the ubiquitin system, which has a fundamental role in regulating various biological activities. PGP9.5 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Recombinant PGP9.5 protein was expressed in E.coli and purified by using conventional chromatography techniques. |
|---|
| Size | 0.5mg, 100ug, 20ug |
|---|
| Concentration | n/a |
|---|
| Applications | Enzyme activity |
|---|
| Other Names | ubiquitin carboxyl-terminal esterase L1, uCHL1, PGP9.5, 1-223aa, uCH-L1, EC 3.4.19.12, ubiquitin thioesterase L1, Neuron cytoplasmic protein 9.5, PGP 9.5, PGP9.5, ubiquitin carboxyl-terminal hydrolase isozyme L1, ubiquitin carboxyl-terminal esterase L1 Gracile axonal dystrophy, Neuron cytoplasmic protein 9.5, Park 5, Parkinson Disease 5, PGP95, uCH L1, Protein gene product 9.5, ubiquitin C terminal esterase L1, ubiquitin C terminal hydrolase (neuron specific), ubiquitin carboxyl terminal esterase L1, ubiquitin carboxyl terminal hydrolase isozyme L1, ubiquitin thiolesterase, ubiquitin thiolesterase L1. |
|---|
| Gene, Accession, CAS # | NP 004172 |
|---|
| Catalog # | PGP0701 |
|---|
| Price | |
|---|
| Order / More Info | PGP9.5, 1-223aa, Human, E.coli (Bioactivity Validated) from ATGen |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|